Dr. Eli Naghdi, DO
NPI: 1770088320
Total Payments
$2,346
2024 Payments
$1,113
Companies
16
Transactions
69
Medicare Patients
2,575
Medicare Billing
$371,480
Payment Breakdown by Category
Food & Beverage$2,346 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,346 | 69 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $632.62 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $560.91 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $173.31 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $135.00 | 1 | $0 (2023) |
| Amgen Inc. | $125.00 | 1 | $0 (2024) |
| OptiNose US, Inc. | $125.00 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $124.94 | 1 | $0 (2023) |
| Melinta Therapeutics, LLC | $109.02 | 4 | $0 (2023) |
| PFIZER INC. | $90.93 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $80.02 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,113 | 36 | ABBVIE INC. ($476.44) |
| 2023 | $764.94 | 25 | Janssen Pharmaceuticals, Inc ($189.34) |
| 2022 | $342.28 | 7 | Janssen Pharmaceuticals, Inc ($276.49) |
| 2021 | $125.00 | 1 | OptiNose US, Inc. ($125.00) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: DIABETES | ||||||
| 11/24/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/19/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: CRITICAL CARE | ||||||
| 11/13/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/09/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $110.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/04/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Cardiovascular | ||||||
| 08/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 07/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/02/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/04/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/08/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,333 | 2,174 | $3.2M | $187,165 |
| 2022 | 8 | 948 | 1,486 | $1.3M | $141,834 |
| 2021 | 5 | 294 | 461 | $202,626 | $42,481 |
Total Patients
2,575
Total Services
4,121
Medicare Billing
$371,480
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 373 | 1,013 | $1.4M | $66,600 | 4.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 257 | 421 | $590,470 | $41,616 | 7.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 370 | 392 | $560,316 | $37,526 | 6.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 182 | 188 | $461,895 | $27,072 | 5.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 64 | 64 | $129,680 | $6,965 | 5.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 75 | 84 | $57,500 | $5,237 | 9.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 12 | $33,000 | $2,149 | 6.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 290 | 624 | $502,380 | $58,290 | 11.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 175 | 368 | $330,972 | $24,247 | 7.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 230 | 236 | $187,524 | $22,931 | 12.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 100 | 100 | $178,676 | $17,993 | 10.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 91 | 93 | $84,690 | $11,208 | 13.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 19 | $32,468 | $3,914 | 12.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 34 | 35 | $16,950 | $2,514 | 14.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 11 | $5,442 | $737.40 | 13.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 78 | 152 | $69,920 | $14,736 | 21.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 93 | 185 | $59,570 | $12,502 | 21.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 77 | 78 | $37,908 | $7,808 | 20.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 27 | 27 | $23,733 | $5,088 | 21.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 19 | $11,495 | $2,347 | 20.4% |
About Dr. Eli Naghdi, DO
Dr. Eli Naghdi, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Syosset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1770088320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eli Naghdi, DO has received a total of $2,346 in payments from pharmaceutical and medical device companies, with $1,113 received in 2024. These payments were reported across 69 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,346).
As a Medicare-enrolled provider, Naghdi has provided services to 2,575 Medicare beneficiaries, totaling 4,121 services with total Medicare billing of $371,480. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Adult Medicine
- Location Syosset, NY
- Active Since 03/27/2018
- Last Updated 09/15/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1770088320
Products in Payments
- XARELTO (Drug) $560.91
- DALVANCE (Drug) $241.51
- TEFLARO (Drug) $225.89
- JARDIANCE (Drug) $173.31
- ELIQUIS (Drug) $135.15
- AUSTEDO (Drug) $135.00
- TEPEZZA (Biological) $125.00
- Xhance (Drug) $125.00
- CYCLOSET (Drug) $124.94
- VRAYLAR (Drug) $110.39
- Kimyrsa (Drug) $84.63
- FARXIGA (Drug) $80.02
- DIFICID (Drug) $64.71
- AVYCAZ (Drug) $54.83
- TERLIVAZ (Drug) $24.42
- Rezzayo (Drug) $24.39
- TRINTELLIX (Drug) $13.24
- Vascepa (Drug) $13.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Syosset
Michael Ashamalla
Student in an Organized Health Care Education/Training Program — Payments: $1,407
Student in an Organized Health Care Education/Training Program $1,407
Dr. Cerise Adams, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $303.80
Student in an Organized Health Care Education/Training Program $303.80
Brian Fiedler, D.o, D.O
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Rita Mccarey
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Mr. Daniel Abbey
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Mrs. Antonia Iavarone, Ccc-Slp, CCC-SLP
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program